Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (235)

« Back to Publications

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Bijukchhe SM. et al, (2026), Lancet Infect Dis

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections

Hagedoorn N. et al, (2026)

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections

Hagedoorn NN. et al, (2026)

Maternal iron status and total immunoglobulin-G influence transplacental antibody transfer across eight diverse geographical settings.

Tiley KS. et al, (2026), Vaccine, 73

"Now that the baby is out, I can be vaccinated": a qualitative study on COVID-19 vaccine hesitancy in pregnant women in Kilifi, Kenya.

Koech A. et al, (2026), Front Public Health, 14

Eight-Year Vaccine Protection Following a Single Dose of VI-Tetanus Toxoid Conjugate Vaccine in Nepali Children: Extended Follow-Up of the TyVAC Nepal Randomised Controlled Trial

Pant D. et al, (2026)

Chapter 3 The epidemiology of human GBS carriage

Trotter C. and Voysey M., (2026), 37 - 44

Modeling Indirect Protection from Typhoid Conjugate Vaccines in the TyVAC-Bangladesh Trial

Walker J. et al, (2025)

Preliminary safety data from a randomised trial of early versus standard timing of administration of measles-rubella vaccine in Ugandan infants

Businge GB. et al, (2025)

A statistical method for evaluating vaccine-induced immune correlates of protection against infection and disease progression: application to the ChAdOx1-S nCoV-19 phase 3 trial.

Williams LR. et al, (2025), Vaccine, 67

A novel approach for estimating vaccine efficacy for infections with multiple outcomes: application to a COVID-19 vaccine trial

Williams LR. et al, (2025), AJE Advances: Research in Epidemiology, 1

Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Walker J. et al, (2025), PLoS Negl Trop Dis, 19

Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222).

Belij-Rammerstorfer S. et al, (2025), EBioMedicine, 118

Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil.

Costa Clemens SA. et al, (2025), Mayo Clin Proc Innov Qual Outcomes, 9

The waning of maternal measles antibodies: A multi-country maternal-infant seroprevalence study.

Tiley KS. et al, (2025), J Infect, 91

Load More

1
2
3
4
5
6
7
...
»